USE OF TUMOR NECROSIS FACTOR INHIBITORS TOGETHER WITH ANTIVIRAL AGENTS AND THERAPEUTIC COMPOSITIONS THEREOF AGAINST HIV INFECTION - Patent 0712310

(19)

(11)

EP 0 712 310 A1

(12)

(43)	Date of publication:
	22.05.1996 Bulletin 1996/21

(21)	Application number: 94922777.0

(22)	Date of filing: 03.08.1994

(51)

International Patent Classification (IPC):

A61K 31/ 00^{( . )}
A61K 31/ 52^{( . )}

A61K 31/ 445^{( . )}

(86)	International application number:
	PCT/US1994/008741

(87)	International publication number:
	WO 1995/004525 (16.02.1995 Gazette 1995/08)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

04.08.1993 US 19930101752

(71)	Applicant: Andrulis Pharmaceuticals Corporation
	Beltsville, MD 20705 (US)

(72)	Inventors:
	ANDRULIS, Peter J., Jr. Bethesda, MD 20817 (US) ANGRES, Issac Gaithersburg, MD 20878 (US)

(74)	Representative: Jones, Helen Marjorie Meredith, et al
	Gill Jennings & Every, Broadgate House, 7 Eldon Street London EC2M 7LH London EC2M 7LH (GB)

(54)	USE OF TUMOR NECROSIS FACTOR INHIBITORS TOGETHER WITH ANTIVIRAL AGENTS AND THERAPEUTIC COMPOSITIONS THEREOF AGAINST HIV INFECTION